scPharmaceuticals Inc. (NASDAQ: SCPH)
$5.09
+0.3600 ( +7.61% ) 400.5K
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.
Market Data
Open
$5.09
Previous close
$4.73
Volume
400.5K
Market cap
$183.16M
Day range
$4.71 - $5.12
52 week range
$3.24 - $8.78
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 14 | May 14, 2024 |
10-q | Quarterly Reports | 69 | May 14, 2024 |
def | Proxies and info statements | 9 | Apr 26, 2024 |
pre | Proxies and info statements | 8 | Apr 12, 2024 |
4 | Insider transactions | 1 | Apr 02, 2024 |
8-k | 8K-related | 15 | Mar 13, 2024 |
10-k | Annual reports | 86 | Mar 13, 2024 |
4 | Insider transactions | 1 | Jan 22, 2024 |
4 | Insider transactions | 1 | Jan 22, 2024 |
8-k | 8K-related | 14 | Jan 04, 2024 |